Trials / Unknown
UnknownNCT05619666
Acute Rehabilitation in Patients With COVID-19 Pneumonia
Acute Rehabilitation in Patients With COVID-19 Pneumonia a Single Center Experience From a Developing Country
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Institut za Rehabilitaciju Sokobanjska Beograd · Academic / Other
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
COVID-19 can have different clinical manifestations including myalgia, arthralgia, neurological, cardiac, psychological and other manifestations.These patients are at greater risk of developing consequences of prolonged bed rest. Therefore physical medicine and rehabilitation could have an important role in the multidisciplinary treatment of these issues. Early respiratory and neuromuscular rehabilitation is necessary to improve functional physical limitations, performance, muscle strength, endurance as well as cognitive and emotional domains. Some studies proposed that rehabilitation protocols in the inpatient setting include early mobilisation, strength and endurance training with the aim of reducing weakness and dependency. This Study aimed to detect the effects of rehabilitation in patients with Covid-19 who were admitted in temporary Covid hospital in Serbia. Furthermore, to emphasize the importance of functional assessment of the patients, in identifying their problems and selections of priorities in planning the best therapeutic protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Acute rehabilitation program | Patients included in the study started the rehabilitation program when they were hemodynamic stable, when it was determined that it was safe for patients. Until discharge from the hospital, a re-evaluation of neuromuscular and respiratory function was performed. |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2022-12-01
- Completion
- 2023-01-01
- First posted
- 2022-11-17
- Last updated
- 2022-11-17
Locations
2 sites across 1 country: Serbia
Source: ClinicalTrials.gov record NCT05619666. Inclusion in this directory is not an endorsement.